TP53 and cancer: Both lines contain homozygous mutations in TP53 which produce transcripts downregulated by NMD, with each exhibiting RNA levels less than 20% of the median level of expression among 675 cancer cell lines (Figure 4C and Figure 4—figure supplement 3; Lindeboom et al., 2016; Klijn et al., 2015).